itraconazole and loperamide: label evidence and limits

The itraconazole capsule label lists loperamide in its interaction table and advises monitoring for adverse reactions; a clinician may need to reduce the concomitant drug’s dose.

Which products this evidence covers

Oral itraconazole capsules; the loperamide row of the interaction table.

What this finding does and does not establish

The original extracted text ran the neighboring aprepitant name into the loperamide entry. This comparison follows the loperamide table row and does not validate CDI’s severity rating.

Supporting label passage

Aprepitant Loperamide a Monitor for adverse reactions. Concomitant drug dose reduction may be necessary.

Read the product label on DailyMed. Section: Drug Interactions — Gastrointestinal Drugs table. Compared label version 27, dated 2026-09-17.

How this brief was prepared

This brief uses an AI-assisted source comparison dated 2026-10-16. The label version and supporting passage were checked again on 2026-10-30. Independent clinical review has not been recorded. The comparison does not validate CDI's severity category or determine individual treatment.

Discuss your exact medicines with your pharmacist

Ask whether the cited formulation and route apply to your products and circumstances. Confirm medication decisions with your pharmacist or prescriber before changing treatment.

Check your medication list with CDI.